explore -WSS

explore

author：comprehensive 2025-09-30 21:57:38 - browse：436

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

WSS

IRA could hurt research into orphan drugs for rare diseases

ASCO Takeaways: Winners, snoozers, and the art of cancer care

An outdated Medicare rule harms dementia patients with anxiety

Acelyrin, a rare IPO success, stumbles in its first big test

New weight loss drugs vying to be the next Wegovy or Mounjaro

Generate Biomedicines machine learning biotech raises $273M

focus

explore

MORE: General Motors recalls over 600K cars due to car seat safety issue

leisure time

Medical records are filled with copy

Stopping antidepressants leads to symptoms for 1 in 6 patients

Drug repurposing or repositioning? The language matters

Take antibiotics after sex, CDC recommends for certain risk groups

Guidelines to prevent youth baseball injuries need more muscle

Sutter Health’s antitrust win overturned by appeals court

Sports medicine is finally prioritizing gender equality

Illumina board agrees to spin off Grail, as divestment plans proceed

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare Advantage's lean provider networks lead CMS complaints

focus

FDA panel endorses Alnylam’s heart drug — after picking it apart

Popular nasal decongestant doesn't actually relieve congestion

Medicare Advantage's lean provider networks lead CMS complaints

Popular nasal decongestant doesn't actually relieve congestion

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

WATCH: Why do bright lights make us see spots?

leisure time

focus

Wikipedia

hotspot